BIOMAT Database Logo BIOMAT Database Logo

Hypertrophic obstructive cardiomyopathy prevention of outflow obstruction with propranolol. 1976

G Vijayaraghavan, and G Cherian

UI MeSH Term Description Entries
D007545 Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. Isoprenaline,Isopropylarterenol,4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol,Euspiran,Isadrin,Isadrine,Isopropyl Noradrenaline,Isopropylnoradrenaline,Isopropylnorepinephrine,Isoproterenol Hydrochloride,Isoproterenol Sulfate,Isuprel,Izadrin,Norisodrine,Novodrin,Hydrochloride, Isoproterenol,Noradrenaline, Isopropyl,Sulfate, Isoproterenol
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D002312 Cardiomyopathy, Hypertrophic A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY). Cardiomyopathy, Hypertrophic Obstructive,Cardiomyopathies, Hypertrophic,Cardiomyopathies, Hypertrophic Obstructive,Hypertrophic Cardiomyopathies,Hypertrophic Cardiomyopathy,Hypertrophic Obstructive Cardiomyopathies,Hypertrophic Obstructive Cardiomyopathy,Obstructive Cardiomyopathies, Hypertrophic,Obstructive Cardiomyopathy, Hypertrophic
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G Vijayaraghavan, and G Cherian
Left ventricular outflow obstruction in a patient with undiagnosed hypertrophic obstructive cardiomyopathy.
December 2007, Canadian journal of anaesthesia = Journal canadien d'anesthesie,
G Vijayaraghavan, and G Cherian
Hypertrophic cardiomyopathy with extreme outflow tract obstruction.
November 2022, European heart journal,
G Vijayaraghavan, and G Cherian
Ultrasound localization of left ventricular outflow obstruction in hypertrophic obstructive cardiomyopathy.
July 1969, Circulation,
G Vijayaraghavan, and G Cherian
[One case of hypertrophic obstructive cardiomyopathy complicated with right ventricle outflow tract obstruction].
April 2018, Zhonghua xin xue guan bing za zhi,
G Vijayaraghavan, and G Cherian
Percutaneous approach for reducing outflow tract obstruction in hypertrophic obstructive cardiomyopathy.
March 2023, Future cardiology,
G Vijayaraghavan, and G Cherian
Hypertrophic cardiomyopathy and outflow tract obstruction.
May 2003, The New England journal of medicine,
G Vijayaraghavan, and G Cherian
Hypertrophic cardiomyopathy and outflow tract obstruction.
May 2003, The New England journal of medicine,
G Vijayaraghavan, and G Cherian
Hypertrophic cardiomyopathy and outflow tract obstruction.
May 2003, The New England journal of medicine,
G Vijayaraghavan, and G Cherian
Spontaneous loss of left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy.
January 1973, Recent advances in studies on cardiac structure and metabolism,
G Vijayaraghavan, and G Cherian
Regression of outflow tract obstruction subsequent to treatment with verapamil in hypertrophic obstructive cardiomyopathy.
September 1990, International journal of cardiology,
Copied contents to your clipboard!